Jane Cheeseman Selected Research

2- methyl- 2- (4- (((4- methyl- 2- (4- trifluoromethylphenyl)- thiazol- 5- ylcarbonyl)amino)methyl)phenoxy)propionic acid

2/2008

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jane Cheeseman Research Topics

Disease

2	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 11/2016
1	Alzheimer Disease (Alzheimer's Disease) 03/2012
1	Obesity 01/2011
1	Acidosis 07/2010
1	Hypoxia (Hypoxemia) 07/2010
1	Polycythemia (Erythrocytosis) 07/2010
1	Multiple Abnormalities 02/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2008
1	Overweight 02/2008

Drug/Important Bio-Agent (IBA)

1	Interleukin-7 (Interleukin 7)IBA 10/2019
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 11/2016
1	Apolipoproteins E (ApoE)IBA 03/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	Oxygen (Dioxygen)IBA 07/2010
1	EnzymesIBA 07/2010
1	Phosphocreatine (Neoton)IBA 07/2010
1	Transcription Factors (Transcription Factor)IBA 07/2010
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2010
1	2- methyl- 2- (4- (((4- methyl- 2- (4- trifluoromethylphenyl)- thiazol- 5- ylcarbonyl)amino)methyl)phenoxy)propionic acidIBA 02/2008
1	GW 501516IBA 02/2008
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2008
1	PPAR deltaIBA 02/2008